Melanoma Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence of melanoma, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Melanoma Information Center has current, evidence-based information for you. Get the facts about melanoma prevention, early detection, treatment, and survivorship, and stay up to date with ongoing melanoma research that could impact your treatment decisions through our daily cancer news.
After many years with few advances several new, targeted and biologic therapies have completed evaluation in clinical trials since 2011. These new treatments have demonstrated improved outcomes for individuals with advanced melanoma leading to their approval by the FDA. Individuals with advanced melanoma now have numerous treatment options. Additional clinical studies are ongoing in order to determine the best way to use these new drugs in sequence or in combination therapy and they are also being evaluated in individuals with earlier stage III disease to reduce the risk of a melanoma recurrence.
You are not alone—The CancerConnect Melanoma Community is the leading Social Media Application for Melanoma patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
Large screening approach demonstrates resistance and aggressive behavior was due to high activity of a cell surface protein called EphA2 Melanoma Research News: Year in Review
After several years of developments in melanoma therapy, 2014 continued FDA Approves Nivolumab for Advanced Melanoma
Nivolumab belongs to a new class of medicines called PD-1 inhibitors that have generated great excitement for their ability to help the immune system recognize and attack cancer.
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Sean Swarner is a master of setting a goal and achieving it. So when he... Jack & Jill Late Stage Cancer Foundation
Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the... Moving Bodies, Changing Lives
Moving On Aerobics helps women regain joy of movement and physical fitness after...
Melanoma Clinical Trials
VicalLX01-315-02 – A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7 Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma
COGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN 2b in Stage T3-T4 or N1 (microscopic) Melanoma
ECOGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN-a2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-2, N1a, 2a (microscopic) Melanoma.